Evidence map›Paper›PMID 23330956›Full record

ReviewAnnual review of immunology2013

Human hemato-lymphoid system mice: current use and future potential for medicine.

Anthony Rongvaux, Hitoshi Takizawa, Till Strowig, Tim Willinger, Elizabeth E Eynon, Richard A Flavell, Markus G Manz

Abstract readReview
In one paragraph

Review in Annual review of immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Applications of humanized mice inMolecular medicine reports · 2026
    Review
  3. Review
  4. Humanized mice enableMolecular therapy. Advances · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Human hematopoiesis and blood cell formation in pigs.Blood science (Baltimore, Md.) · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Preclinical models in the study of lymph node metastasis.Journal of Zhejiang University. Science. B · 2025
    Review
  15. Article
  16. Managing allorejection in off-the-shelf CAR-engineered cell therapies.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anthony RongvauxDepartment of Immunobiology, Yale University, New Haven, Connecticut 06520.
Hitoshi TakizawaDivision of Hematology, University Hospital Zürich, CH-8091 Zürich, Switzerland.
Till StrowigDepartment of Immunobiology, Yale University, New Haven, Connecticut 06520.
Tim WillingerDepartment of Immunobiology, Yale University, New Haven, Connecticut 06520.
Elizabeth E EynonDepartment of Immunobiology, Yale University, New Haven, Connecticut 06520.
Richard A Flavell *Department of Immunobiology, Yale University, New Haven, Connecticut 06520.
Markus G Manz *Division of Hematology, University Hospital Zürich, CH-8091 Zürich, Switzerland.

Funding

Understanding Hemotopoietic Neoplasias using Humanized MiceR01CA156689 · NCI · YALE UNIVERSITY · PI DHODAPKAR, MADHAV V, FLAVELL, RICHARD A · 2010 to 2014
$5.0M
Howard Hughes Medical InstituteNCI NIH HHS CA156689NCI NIH HHS R01 CA156689
6 · The paper itself

Abstract

To directly study complex human hemato-lymphoid system physiology and respective system-associated diseases in vivo, human-to-mouse xenotransplantation models for human blood and blood-forming cells and organs have been developed over the past three decades. We here review the fundamental requirements and the remarkable progress made over the past few years in improving these systems, the current major achievements reached by use of these models, and the future challenges to more closely model and study human health and disease and to achieve predictive preclinical testing of both prevention measures and potential new therapies.

Indexed as

Models, AnimalAnimalsHematopoiesisHematopoietic Stem Cell TransplantationHumansImmunophenotypingLymphoid TissueMiceTranslational Research, BiomedicalTransplantation, Heterologous

Identifiers

PMID23330956
PMCPMC4120191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.